Uwe Pelzer

8.6k total citations
135 papers, 3.0k citations indexed

About

Uwe Pelzer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Uwe Pelzer has authored 135 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Oncology, 50 papers in Pulmonary and Respiratory Medicine and 47 papers in Surgery. Recurrent topics in Uwe Pelzer's work include Pancreatic and Hepatic Oncology Research (99 papers), Cancer Genomics and Diagnostics (32 papers) and Neuroendocrine Tumor Research Advances (22 papers). Uwe Pelzer is often cited by papers focused on Pancreatic and Hepatic Oncology Research (99 papers), Cancer Genomics and Diagnostics (32 papers) and Neuroendocrine Tumor Research Advances (22 papers). Uwe Pelzer collaborates with scholars based in Germany, United States and Spain. Uwe Pelzer's co-authors include Hanno Riess, Helmut Oettle, Jens Stieler, Bernd Dörken, Marianne Sinn, Ingo Schwaner, Marcus Bahra, Sven Bischoff, Jörg Seraphin and Andreas Hilbig and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Uwe Pelzer

118 papers receiving 3.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Uwe Pelzer 2.1k 801 800 749 597 135 3.0k
Jens Stieler 1.4k 0.6× 523 0.7× 532 0.7× 526 0.7× 386 0.6× 51 2.1k
Florian Posch 1.2k 0.6× 675 0.8× 375 0.5× 656 0.9× 337 0.6× 136 3.6k
Mohammad Jahanzeb 855 0.4× 486 0.6× 229 0.3× 204 0.3× 117 0.2× 69 1.7k
Paul E. Van Schil 1.2k 0.6× 2.0k 2.5× 378 0.5× 436 0.6× 100 0.2× 68 2.7k
Fabio A.B. Schutz 1.4k 0.7× 1.2k 1.5× 281 0.4× 533 0.7× 163 0.3× 46 2.9k
Karen Borgonovo 2.7k 1.3× 1.5k 1.9× 639 0.8× 667 0.9× 178 0.3× 83 3.8k
Diane Mège 1.1k 0.5× 310 0.4× 210 0.3× 1.1k 1.5× 184 0.3× 115 2.2k
Lucy E. Hann 600 0.3× 649 0.8× 847 1.1× 1.3k 1.7× 179 0.3× 74 3.1k
Paul Stonelake 433 0.2× 218 0.3× 369 0.5× 252 0.3× 122 0.2× 40 1.5k
Marina Marchetti 448 0.2× 286 0.4× 177 0.2× 286 0.4× 165 0.3× 100 3.6k

Countries citing papers authored by Uwe Pelzer

Since Specialization
Citations

This map shows the geographic impact of Uwe Pelzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Pelzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Pelzer more than expected).

Fields of papers citing papers by Uwe Pelzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Pelzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Pelzer. The network helps show where Uwe Pelzer may publish in the future.

Co-authorship network of co-authors of Uwe Pelzer

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Pelzer. A scholar is included among the top collaborators of Uwe Pelzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Pelzer. Uwe Pelzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pelzer, Uwe, F Schneider, Anna Luisa Kühn, et al.. (2025). Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoids. Cancer Cell International. 25(1). 321–321.
3.
Bayerl, Christian, Julian M.M. Rogasch, Christian Furth, et al.. (2024). 68Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapy. Theranostics. 14(11). 4184–4197. 3 indexed citations
4.
Wittenbecher, Friedrich, Jörg Westermann, Peter Thuss‐Patience, et al.. (2024). Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessment. Palliative Care and Social Practice. 18. 396558216–396558216.
5.
Krenzien, Felix, Dominik Geisel, Bernd Hamm, et al.. (2024). Intrahepatic Mass-Forming Cholangiocarcinoma: Is There Additional Prognostic Value in Using Gd-EOB Enhanced MRI?. Cancers. 16(7). 1314–1314.
6.
Hummel, Thomas, et al.. (2024). Smell and Taste Alterations in Patients Receiving Curative or Palliative Chemotherapy—The CONKO 021—ChemTox Trial. Cancers. 16(14). 2495–2495. 1 indexed citations
7.
Sinn, Marianne, Uwe Pelzer, Hanno Riess, et al.. (2024). KRT81 and HNF1A expression in pancreatic ductal adenocarcinoma: investigation of predictive and prognostic value of immunohistochemistry‐based subtyping. The Journal of Pathology Clinical Research. 10(3). e12377–e12377. 1 indexed citations
8.
Beetz, Nick Lasse, Timo Alexander Auer, Felix Krenzien, et al.. (2024). Beyond body mass index: Body composition profiling for perioperative risk stratification in intrahepatic cholangiocarcinoma patients. Cancer Reports. 7(9). e2070–e2070.
9.
Neumann, Christopher, F Schneider, Georg Hilfenhaus, et al.. (2023). Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients—A Single Center Analysis of 2323 Patients within the Last Decade. Journal of Clinical Medicine. 12(11). 3656–3656. 5 indexed citations
10.
Auer, Timo Alexander, Federico Collettini, Uwe Pelzer, et al.. (2023). Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma. Cancers. 15(9). 2655–2655. 5 indexed citations
11.
Lurje, Isabella, Deniz Uluk, Dennis Eurich, et al.. (2023). Body composition is associated with disease aetiology and prognosis in patients undergoing resection of intrahepatic cholangiocarcinoma. Cancer Medicine. 12(17). 17569–17580. 10 indexed citations
12.
Neumann, Christopher, F Schneider, Georg Hilfenhaus, et al.. (2023). Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients—A Single-Center Analysis of 1294 Patients within the Last Decade. Cancers. 15(8). 2367–2367. 11 indexed citations
13.
Riess, Hanno, Jan Beyer‐Westendorf, Uwe Pelzer, Robert Klamroth, & Birgit Linnemann. (2023). Cancer-Associated Venous Thromboembolism—Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline. Hämostaseologie. 44(2). 143–149. 4 indexed citations
14.
Auer, Timo Alexander, Thula Walter, Uwe Pelzer, et al.. (2023). Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it’s not all about size. Abdominal Radiology. 48(10). 3063–3071. 7 indexed citations
15.
Auer, Timo Alexander, Uli Fehrenbach, Uwe Pelzer, et al.. (2023). Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5th edition of the World Health Organization classification. European Radiology. 33(10). 6902–6915. 7 indexed citations
16.
Uluk, Deniz, Isabella Lurje, Cornelius Engelmann, et al.. (2022). Prognostic and Predictive Molecular Markers in Cholangiocarcinoma. Cancers. 14(4). 1026–1026. 29 indexed citations
17.
Felsenstein, Matthäus, Mathilde Feist, Karl H. Hillebrandt, et al.. (2022). Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies?. Journal of Clinical Medicine. 11(9). 2367–2367. 21 indexed citations
18.
Beetz, Nick Lasse, Dominik Geisel, Christoph Maier, et al.. (2022). Influence of Baseline CT Body Composition Parameters on Survival in Patients with Pancreatic Adenocarcinoma. Journal of Clinical Medicine. 11(9). 2356–2356. 12 indexed citations
19.
20.
Roehle, Robert, Uwe Pelzer, Marcus Bahra, et al.. (2019). Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma. European Journal of Radiology. 119. 108626–108626. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens Stieler Breakdown of academic impact, for papers by Florian Posch Breakdown of academic impact, for papers by Mohammad Jahanzeb Breakdown of academic impact, for papers by Paul E. Van Schil Breakdown of academic impact, for papers by Fabio A.B. Schutz Breakdown of academic impact, for papers by Karen Borgonovo Breakdown of academic impact, for papers by Diane Mège Breakdown of academic impact, for papers by Lucy E. Hann Breakdown of academic impact, for papers by Paul Stonelake Breakdown of academic impact, for papers by Marina Marchetti
Rankless by CCL
2026